Many potentially effective drugs have failed to become viable medicines because of drug solubility or manufacturing processing limitations. At DisperSol, our mission is to use our proprietary KinetiSol technology to make new and better medicines to help patients.

KINETISOL BENEFITS

Removing Barriers
for New Medicines

We can enable drugs that have been previously insoluble with KinetiSol.

Fast and Easy
Process

KinetiSol can take you from project start to first clinical study in under 6 months.

Can Outperform Spray Drying & Melt Extrusion

Other drug formulation technologies cannot compete with our ability to process novel, GRAS excipients that allow for the creation of superior formulations.